Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(16/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(16/week)
News
United States
(1411/week)
Manufacturing
(719/week)
Energy
(555/week)
Technology
(1432/week)
Alternative Energy
(170/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Sangamo Therapeutics, Inc.
Jan 04, 2019
Sangamo Therapeutics To Present at the 37th Annual J.P. Morgan Healthcare Conference
Jan 04, 2019
Sangamo Announces Upcoming Clinical Data Presentations At WORLDSymposium 2019
Dec 17, 2018
Sangamo Announces Treatment Of First Patient In Phase 1/2 Clinical Trial Of In Vivo Genome Editing Therapy For Hemophilia B
Dec 03, 2018
Sangamo Announces Completion Of TxCell Acquisition
Nov 08, 2018
Sangamo Therapeutics Reports Third Quarter 2018 Financial Results
Nov 06, 2018
Sangamo Therapeutics Announces Participation At Upcoming Investor Conferences
Nov 01, 2018
Sangamo Therapeutics Announces Third Quarter 2018 Conference Call and Webcast
Oct 01, 2018
Sangamo and TxCell announce the completion of the acquisition by Sangamo of majority of TxCell ordinary shares
Sep 24, 2018
Sangamo Therapeutics Announces Participation At Upcoming Investor and Industry Conferences
Sep 05, 2018
Sangamo Announces 16 Week Clinical Results Including Reductions In Glycosaminoglycans In Phase 1/2 Trial Evaluating SB-913, A Zinc Finger Nuclease Genome Editing Treatment For MPS II (Hunter Syndrome)
Aug 30, 2018
Sangamo Therapeutics Announces Conference Call To Review SB-913 CHAMPIONS Study Data And Participation At Upcoming Investor Conferences
Aug 10, 2018
Sangamo Therapeutics Announces Presentation At The 2018 Wedbush PacGrow Healthcare Conference
Aug 08, 2018
Sangamo Therapeutics Reports Second Quarter 2018 Financial Results
Aug 02, 2018
Sangamo Therapeutics Announces Second Quarter 2018 Conference Call and Webcast
Jul 31, 2018
Sangamo Announces Preliminary Data From Champions Study Evaluating SB-913, An Investigational Genome Editing Treatment For MPS II, To Be Presented September 5th At SSIEM 2018 Symposium
Jul 27, 2018
Sangamo To Host Educational Webcast With Hunter Syndrome (MPS II) Expert, Joseph Muenzer, M.D., Ph.D.
Jul 23, 2018
Sangamo Announces Treatment Of First Patient In Phase 1/2 Clinical Trial Evaluating SB-318 Investigational In Vivo Genome Editing Therapy For MPS I
Jul 23, 2018
Sangamo Therapeutics to Acquire TxCell
Jun 28, 2018
Sangamo Therapeutics Appoints Karen Smith to its Board of Directors
Jun 04, 2018
Sangamo Announces U.K. Authorization Of Clinical Trials Evaluating Zinc Finger Nuclease In Vivo Genome Editing Treatments SB-318 For MPS I And SB-913 For MPS II
‹‹
Page 2
››
Latest News
May 22, 2024
Watts Water Technologies, Inc. to Participate in the KeyBanc Capital Markets’ Industrials & Basic...
May 22, 2024
nVent Electric plc to Participate in the William Blair Growth Stock Conference
May 22, 2024
NewSouth Window Solutions Donates Windows to Local First Responders and Nonprofit
May 22, 2024
IDENTOS Celebrates 10 Years of Innovation and Growth
May 22, 2024
PowerFlex Kicks Off Reseller Partner Program for EV Charging Solutions
May 22, 2024
Aqua Pennsylvania Secures up to $6.7 Million PENNVEST Grant for PFAS Treatment Facility Serving 25,000 People...
May 22, 2024
Cleveland-Cliffs Reminds U.S. Steel: You Have No Path to Close
May 22, 2024
Avangrid Boosts Resiliency and Reliability of Onshore Portfolio with First Mobile Transformer
View all News
Agenda
29
October
United Kingdom
Copthorne Tara Hotel, London, UK
International Dismounted Soldier, 29-30 October 2024, Copthorne Tara Hotel, London, UK
Navigating the Evolving Battlespace: Enhancing the Capabilities of the Dismounted Soldier The modern battlefield...
24
September
United Kingdom
Hilton London Syon Park, London, UK
Defence Transformation Conference, 24-26 September 2024, Hilton London Syon Park, London, UK
Returning for its 8th year, Defence Transformation 2024 will feature an updated format that will address all aspects of...
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
View All Events